article Open AccessTop 1% cited

Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary

European Respiratory Journal · 2023 · Vol. 61(4) · pp. 2300239–2300239

Àlvar Agustí✉(Health First)Bartolomé R. Celli(Brigham and Women's Hospital)Gerard J. Criner(Temple University)David Halpin(University of Exeter)Antonio Anzueto(South Texas Veterans Health Care System)Peter J. Barnes(Imperial College London)Jean Bourbeau(McGill University Health Centre)MeiLan K. Han(University of Michigan)Fernando J. Martínez(NewYork–Presbyterian Hospital)María Montes de(Hospital Clínico Universitario de Caracas)Kevin Mortimer(University of Liverpool)Alberto Papi(University of Ferrara)Ian Pavord(University of Oxford)Nicolás Roche(Hôpital Cochin)Sundeep SalviDon D. Sin(University of British Columbia)Dave Singh(University of Manchester)Robert A. Stockley(NIHR Surgical Reconstruction and Microbiology Research Centre)María Victorina López Varela(Universidad de la República de Uruguay)Jadwiga A. Wedzicha(Imperial College London)Claus Vogelmeier(German Center for Lung Research)

View via DOI Full-text PDF

Abstract

<b>Executive summary of the Global Strategy for Prevention, Diagnosis and Management of COPD 2023: the latest evidence-based strategy document from the Global Initiative for Chronic Obstructive Lung Disease (GOLD</b><b>)</b> https://bit.ly/3KCaTGe

Chronic Obstructive Pulmonary Disease (COPD) Research Respiratory Support and Mechanisms Asthma and respiratory diseasesMedicineObstructive lung diseaseCOPDLung diseaseExecutive summaryPulmonary diseaseGold standard (test)Intensive care medicineLungInternal medicine